Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathologyJulien Chapuis, Kristof Van Kolen, Yoann Sottejeau et al.|Molecular Psychiatry|2013Cited by 440
Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathologyPierre Dourlen, Bart Dermaut, Yoann Sottejeau et al.|Molecular Psychiatry|2016Cited by 119
Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domainYoann Sottejeau, Jean‐Charles Lambert, Amandine Flaig et al.|Acta Neuropathologica Communications|2015Cited by 98
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Jean‐Charles Lambert, Anne‐Marie Ayral et al.|EBioMedicine|2016Cited by 52